ORIC logo

ORIC Pharmaceuticals (ORIC)

Profile

Full Name

ORIC Pharmaceuticals, Inc.

Ticker Symbol

ORIC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 24, 2020

Indexes

Not included

Website

http://www.oricpharma.com

Employees

115

Key Details

Price

$5.11(+3.86%)

Market cap

$362.95M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.83(+6.63% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.11
ORIC price is $5.11

30-Day Relative Volume

0.89
ORIC 30-day relative volume is 0.89

Price Performance

Price Most recent change

+3.86%
ORIC price was up +3.86% on Apr 14, 2025

Price YTD change

-36.68%
ORIC price is down -36.68% since January 1st

Price 1-year change

-47.86%
ORIC price is down -47.86% year-on-year

Price 3-year change

+13.56%
ORIC price is up +13.56% over the past 3 years

Price Range

Price All-time high

$40.81
ORIC price is currently -87.48% below its historical high of $40.81

Price 3-year low

$2.36
ORIC price is currently +116.53% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$362.95M
ORIC market capitalization is $362.95 million

Market cap 3-year change

+104.51%
ORIC market capitalization is up +104.51% over the past 3 years

Market cap All-time high

$1.42B
ORIC market capitalization is currently -74.38% below its historical high of $1.42 billion

Market cap sector rank

65.21%
ORIC market capitalization is higher than 65.21% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+5.35%
ORIC shares outstanding is up +5.35% year-on-year

Shares Outstanding 3-Year Change

+80.09%
ORIC shares outstanding is up +80.09% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.54
ORIC beta is 1.54

200-day SMA

$9.04
ORIC price is currently -43.47% below its 200-day simple moving average

50-day SMA

$7.58
ORIC price is currently -32.54% below its 50-day simple moving average

RSI

39.42
ORIC 14-day relative strength index is 39.42

Volume

0.89
ORIC 30-day relative volume is 0.89

ATR

$0.61
ORIC average true range is $0.61

10-day Historical Volatility

132.27%
ORIC 10-day historical volatility is 132.27%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ORIC annual revenue value is unknown

Revenue Analysts estimate

-
ORIC annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ORIC annual revenue 1-year change is unknown

Revenue Sector rank

-
ORIC annual revenue is unknown

EPS

EPS

-$1.83
ORIC annual earnings per share is -$1.83

EPS Analysts estimate

-$1.99
ORIC annual earnings per share is currently -7.81% lower than the consensus analysts' forecast

EPS 1-year change

+6.63%
ORIC annual earnings per share is up +6.63% year-on-year

EPS Sector rank

40.2%
ORIC annual earnings per share is higher than 40.2% of companies in Healthcare sector

Profit

Gross profit

-
ORIC annual gross profit value is unknown

Gross margin

-
ORIC annual gross profit margin value is unknown

Operating profit

-$142.90M
ORIC annual operating income is -$142.90 million

Operating margin

-
ORIC annual operating profit margin value is unknown

Net income

-$127.85M
ORIC annual net profit is -$127.85 million

Net margin

-
ORIC annual net profit margin value is unknown

Expenses

Total expenses

$142.90M
ORIC annual total expenses is $142.90 million

Operating expenses

$142.90M
ORIC annual total operating expenses is $142.90 million

Cost of goods sold

-
ORIC annual cost of goods sold value is unknown

Selling, general & administrative expenses

$28.82M
ORIC annual SGA is $28.82 million

Depreciation and amortization

$1.11M
ORIC annual depreciation & amortization is $1.11 million

Interest expense

-
ORIC annual interest expense value is unknown

Income tax

-
ORIC annual income tax value is unknown

EBIT & EBITDA

EBIT

-$142.90M
ORIC annual earnings before interest & taxes is -$142.90 million

EBITDA

-$141.79M
ORIC annual EBITDA is -$141.79 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$274.14M
ORIC annual total assets is $274.14 million

Non current assets

$11.89M
ORIC annual long term assets is $11.89 million

Current assets

$262.25M
ORIC annual total current assets is $262.25 million

Cash and cash equivalents

$59.41M
ORIC annual cash & cash equivalents is $59.41 million

Accounts receivable

-
ORIC annual accounts receivable value is unknown

Inventory

-
ORIC annual inventory value is unknown

Liabilities

Total liabilities

$31.02M
ORIC annual total liabilities is $31.02 million

Long term liabilities

$6.17M
ORIC annual total long term liabilities is $6.17 million

Current liabilities

$24.85M
ORIC annual total current liabilities is $24.85 million

Accounts payable

$1.55M
ORIC annual accounts payable is $1.55 million

Debt

Total debt

$3.18M
ORIC annual total debt is $3.18 million

Total debt 1-year change

+15.66%
ORIC annual total debt is up +15.66% year-on-year

Long term debt

-
ORIC annual long term debt value is unknown

Short term debt

$3.18M
ORIC annual short term debt is $3.18 million

Equity & Capital

Shareholders equity

$243.12M
ORIC annual stockholders equity is $243.12 million

Book value

$243.12M
ORIC annual book value is $243.12 million

Retained earnings

-$562.77M
ORIC annual retained earnings is -$562.77 million

Working capital

$237.40M
ORIC annual working capital is $237.40 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$112.66M
ORIC annual cash flow from operations is -$112.66 million

Cash from operations 1-year change

-31.48%
ORIC annual cash flow from operations is down -31.48% year-on-year

Cash from investing

$22.14M
ORIC annual cash flow from investing activities is $22.14 million

Cash from investing 1-year change

+151%
ORIC annual cash flow from investing activities is up +151% year-on-year

Cash from financing

$126.55M
ORIC annual cash flow from financing activities is $126.55 million

Cash from financing 1-year change

+47.74%
ORIC annual cash flow from financing activities is up +47.74% year-on-year

CAPEX

CAPEX

-
ORIC annual capital expenditures value is unknown

CAPEX 1-year change

-
ORIC annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$113.85M
ORIC annual free cash flow is -$113.85 million

Free cash flow 1-year change

-31.56%
ORIC annual free cash flow is down -31.56% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ORIC annual gross profit margin value is unknown

Operating margin

-
ORIC annual operating profit margin value is unknown

Net margin

-
ORIC annual net profit margin value is unknown

ROA & ROE

ROA

-46.64%
ORIC annual return on assets is -46.64%

ROE

-52.59%
ORIC annual return on equity is -52.59%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ORIC price to earnings ratio value is unknown

PE ratio Sector rank

-
ORIC price to earnings ratio is unknown

PB Ratio

PB ratio

1.49
ORIC price to book ratio is 1.49

PB ratio Sector rank

54.73%
ORIC price to book ratio is higher than 54.73% of companies in Healthcare sector

PS Ratio

PS ratio

-
ORIC price to sales ratio value is unknown

PS ratio Sector rank

-
ORIC price to sales ratio is unknown

Enterprise value

Enterprise value

$306.72M
ORIC enterprise value is $306.72 million

Enterprise value Sector rank

63.31%
ORIC enterprise value is higher than 63.31% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.16
ORIC EV/EBITDA is -2.16

EV/EBITDA Sector rank

30.43%
ORIC EV/EBITDA is higher than 30.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

10.56
ORIC annual current ratio is 10.56

Quick ratio

-
ORIC annual quick ratio value is unknown

Leverage

Debt to equity

0.01
ORIC annual debt to equity ratio is 0.01

Interest coverage ratio

-
ORIC annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ORIC piotroski f-score value is unknown

Altman Z-Score

-
ORIC altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Feb 26, 25 JP Morgan
Overweight
Feb 26, 25 HC Wainwright & Co.
Buy
Feb 26, 25 Guggenheim
Buy
Feb 24, 25 HC Wainwright & Co.
Buy
Feb 21, 25 HC Wainwright & Co.
Buy
Feb 11, 25 HC Wainwright & Co.
Buy
Feb 10, 25 Guggenheim
Buy
Feb 6, 25 JP Morgan
Overweight
Jan 14, 25 Cantor Fitzgerald
Overweight
Jan 13, 25 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

TRML logo
Tourmaline Bio (TRML)
Maze Therapeutics (MAZE)
KMDA logo
Kamada (KMDA)
TBRG logo
TruBridge (TBRG)
VERV logo
Verve Therapeutics (VERV)
Rapport Therapeutics (RAPP)
CYH logo
Community Health Systems (CYH)
ETON logo
Eton Pharmaceuticals (ETON)
CELC logo
Celcuity (CELC)
  • What is the ticker symbol for ORIC Pharmaceuticals?
  • Does ORIC Pharmaceuticals pay dividends?
  • What sector is ORIC Pharmaceuticals in?
  • What industry is ORIC Pharmaceuticals in?
  • What country is ORIC Pharmaceuticals based in?
  • When did ORIC Pharmaceuticals go public?
  • Is ORIC Pharmaceuticals in the S&P 500?
  • Is ORIC Pharmaceuticals in the NASDAQ 100?
  • Is ORIC Pharmaceuticals in the Dow Jones?
  • When was ORIC Pharmaceuticals's last earnings report?
  • When does ORIC Pharmaceuticals report earnings?
  • Should I buy ORIC Pharmaceuticals stock now?

What is the ticker symbol for ORIC Pharmaceuticals?

The ticker symbol for ORIC Pharmaceuticals is NASDAQ:ORIC

Does ORIC Pharmaceuticals pay dividends?

No, ORIC Pharmaceuticals does not pay dividends

What sector is ORIC Pharmaceuticals in?

ORIC Pharmaceuticals is in the Healthcare sector

What industry is ORIC Pharmaceuticals in?

ORIC Pharmaceuticals is in the Biotechnology industry

What country is ORIC Pharmaceuticals based in?

ORIC Pharmaceuticals is headquartered in United States

When did ORIC Pharmaceuticals go public?

ORIC Pharmaceuticals's initial public offering (IPO) was on April 24, 2020

Is ORIC Pharmaceuticals in the S&P 500?

No, ORIC Pharmaceuticals is not included in the S&P 500 index

Is ORIC Pharmaceuticals in the NASDAQ 100?

No, ORIC Pharmaceuticals is not included in the NASDAQ 100 index

Is ORIC Pharmaceuticals in the Dow Jones?

No, ORIC Pharmaceuticals is not included in the Dow Jones index

When was ORIC Pharmaceuticals's last earnings report?

ORIC Pharmaceuticals's most recent earnings report was on Feb 19, 2025

When does ORIC Pharmaceuticals report earnings?

The next expected earnings date for ORIC Pharmaceuticals is May 6, 2025

Should I buy ORIC Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page